It’s definitely a privilege. Kids get to hear something for the first time, especially in primary school. You might be ...
Celltrion, Inc. today announced that a post-hoc analysis of the LIBERTY-CD study, which showed that the efficacy of ZYMFENTRA® (infliximab-dyyb) is consistent regardless of disease location, has been ...
UNESCO also invited two legal experts from the Fiji National University, Patricia Chand and Sanjana Datt, to introduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback